867 results on '"Willemze, Rein"'
Search Results
2. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
3. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2023
4. Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator
5. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
6. Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
7. Indolent Cutaneous T-Cell Lymphomas
8. Primary cutaneous lymphoma: the 2018 update of the WHO-EORTC classification
9. Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
10. Cutaneous lymphoproliferative disorders: Back to the future
11. Cutaneous T-Cell Lymphomas in Childhood and Adolescence
12. Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T‐cell lymphoma on quality of life
13. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire
14. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
15. Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients.
16. One-year assessment of consultations at the Dutch national referral and expertise center for cutaneous lymphomas
17. Detection of circulating tumor DNA in liquid biopsies of patients with primary cutaneous diffuse large B-cell lymphoma, leg type
18. An overview of the epidemiology and therapeutical modalities in 426 patients with mycosis fungoides and folliculotropic mycosis fungoides in the Netherlands: a retrospective cohort study
19. Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group
20. Detection of Circulating Tumor DNA for Disease Monitoring in Patients with Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
21. PD-1 Overexpression in Sézary Syndrome Is Epigenetically Regulated
22. Data from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas
23. Supplementary Table 1, Figures 1 - 4 from Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones and Carcinomas
24. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
25. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma
26. Data from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
27. Supplementary Figure 1 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
28. Supplementary Table 4 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
29. Supplementary Table 3 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
30. Supplementary Table 2 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
31. Supplementary Table 1 from Novel and Highly Recurrent Chromosomal Alterations in Sézary Syndrome
32. Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”
33. Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
34. P-189 - The impact of advanced-stage cutaneous T-cell lymphoma on quality of life: a qualitative study
35. O-140 - An overview of the epidemiology and therapeutical modalities in 426 patients with mycosis fungoides and folliculotropic mycosis fungoides in the Netherlands: a retrospective cohort study
36. O-125 - Detection of circulating tumor DNA in liquid biopsies of patients with primary cutaneous diffuse large B-cell lymphoma, leg type
37. O-121 - One-year assessment of consultations at the Dutch national referral and expertise center for cutaneous lymphomas
38. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
39. Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
40. Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
41. Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring
42. Tumor Clone Frequency Calculation Using High-Throughput Sequencing of the TCRβ Gene in Patients with Folliculotropic Mycosis Fungoides
43. CD30-Negative Cutaneous T-Cell Lymphomas Other than Mycosis Fungoides
44. Folliculotropic mycosis fungoides presenting with a solitary lesion: Clinicopathological features and long‐term follow‐up data in a series of 9 cases
45. TOX expression in cutaneous B-cell lymphomas
46. Clinical, histopathological and prognostic features of primary cutaneous acral CD8 + T‐cell lymphoma and other dermal CD8 + cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop*
47. Clinical Staging and Prognostic Factors in Folliculotropic Mycosis Fungoides
48. Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider.
49. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases
50. Mass Cytometric Analysis of Early-Stage Mycosis Fungoides
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.